Cardiovascular Systems, Inc. (CSII): Price and Financial Metrics


Cardiovascular Systems, Inc. (CSII): $33.52

0.30 (+0.90%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

CSII POWR Grades


  • Quality is the dimension where CSII ranks best; there it ranks ahead of 75.53% of US stocks.
  • The strongest trend for CSII is in Stability, which has been heading up over the past 51 weeks.
  • CSII ranks lowest in Sentiment; there it ranks in the 36th percentile.

CSII Stock Summary

  • CSII's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 183.21 -- higher than 85.86% of US-listed equities with positive expected earnings growth.
  • For CSII, its debt to operating expenses ratio is greater than that reported by only 13.32% of US equities we're observing.
  • CSII's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of only 15.56% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Cardiovascular Systems Inc are AUTO, ESTA, VAPO, ATRI, and REKR.
  • CSII's SEC filings can be seen here. And to visit Cardiovascular Systems Inc's official web site, go to www.csi360.com.

CSII Valuation Summary

  • In comparison to the median Healthcare stock, CSII's price/sales ratio is 50.66% lower, now standing at 5.6.
  • Over the past 185 months, CSII's price/sales ratio has gone down 81.9.
  • CSII's price/sales ratio has moved down 81.9 over the prior 185 months.

Below are key valuation metrics over time for CSII.

Stock Date P/S P/B P/E EV/EBIT
CSII 2021-08-31 5.6 5.3 -107.2 -121.4
CSII 2021-08-30 5.4 5.2 -105.1 -118.9
CSII 2021-08-27 5.5 5.3 -106.0 -120.0
CSII 2021-08-26 5.4 5.2 -105.0 -118.8
CSII 2021-08-25 5.5 5.3 -106.4 -120.4
CSII 2021-08-24 5.6 5.4 -108.4 -122.8

CSII Growth Metrics

  • The year over year net income to common stockholders growth rate now stands at -119.81%.
  • Its year over year revenue growth rate is now at -12.09%.
  • Its 5 year net income to common stockholders growth rate is now at 72%.
CSII's revenue has moved up $74,912,000 over the prior 70 months.

The table below shows CSII's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 258.973 -0.884 -13.421
2021-03-31 230.532 -13.761 -23.302
2020-12-31 228.434 -11.452 -20.187
2020-09-30 232.599 -9.207 -23.532
2020-06-30 236.545 -12.765 -27.236
2020-03-31 262.233 3.876 -10.601

CSII's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • CSII has a Quality Grade of B, ranking ahead of 75.6% of graded US stocks.
  • CSII's asset turnover comes in at 0.745 -- ranking 43rd of 185 Medical Equipment stocks.
  • NVRO, KRMD, and CRY are the stocks whose asset turnover ratios are most correlated with CSII.

The table below shows CSII's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.745 0.764 -0.051
2021-03-31 0.670 0.780 -0.109
2020-12-31 0.731 0.786 -0.110
2020-09-30 0.827 0.791 -0.161
2020-06-30 0.945 0.794 -0.232
2020-03-31 1.192 0.801 -0.078

CSII Price Target

For more insight on analysts targets of CSII, see our CSII price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $45.88 Average Broker Recommendation 1.65 (Moderate Buy)

CSII Stock Price Chart Interactive Chart >

Price chart for CSII

CSII Price/Volume Stats

Current price $33.52 52-week high $48.28
Prev. close $33.22 52-week low $31.20
Day low $33.47 Volume 147,900
Day high $34.04 Avg. volume 212,036
50-day MA $35.00 Dividend yield N/A
200-day MA $39.26 Market Cap 1.36B

Cardiovascular Systems, Inc. (CSII) Company Bio


Cardiovascular Systems develops, manufactures, and markets devices for the treatment of vascular diseases, targeting a range of plaque types in leg arteries above and below the knee. The company was founded in 1989 and is based in St. Paul, Minnesota.


CSII Latest News Stream


Event/Time News Detail
Loading, please wait...

CSII Latest Social Stream


Loading social stream, please wait...

View Full CSII Social Stream

Latest CSII News From Around the Web

Below are the latest news stories about Cardiovascular Systems Inc that investors may wish to consider to help them evaluate CSII as an investment opportunity.

Cardiovascular Systems, Inc. to Webcast Fiscal 2022 First-Quarter Earnings Conference Call Tuesday, November 9

ST. PAUL, Minn., October 11, 2021--CARDIOVASCULAR SYSTEMS, INC. TO WEBCAST FISCAL 2022 FIRST-QUARTER EARNINGS CONFERENCE CALL TUESDAY, NOVEMBER 9

Yahoo | October 11, 2021

Cardiovascular Systems (CSII) Treats 1st Patient With ViperCross

Cardiovascular Systems' (CSII) ViperCross offers the correct balance of support and flexibility to navigate tortuous anatomy and cross challenging lesions.

Yahoo | September 30, 2021

Cardiovascular Systems, Inc. Announces First Patient Treated with ViperCross Peripheral Support Catheter

ST. PAUL, Minn.--(BUSINESS WIRE)--CARDIOVASCULAR SYSTEMS, INC. ANNOUNCES FIRST PATIENT TREATED WITH VIPERCROSS PERIPHERAL SUPPORT CATHETER

Business Wire | September 29, 2021

Cardiovascular Systems, Inc. Announces First Patient Treated with ViperCross™ Peripheral Support Catheter

ST. PAUL, Minn., September 29, 2021--CARDIOVASCULAR SYSTEMS, INC. ANNOUNCES FIRST PATIENT TREATED WITH VIPERCROSS™ PERIPHERAL SUPPORT CATHETER

Yahoo | September 29, 2021

Cardiovascular Medical Lasers Global Market Report 2021: COVID-19 Growth And Change To 2030

Major players in the cardiovascular medical lasers market are Boston Scientific Corp, Cardiovascular Systems, AngioDynamics, Royal Philips NV, and RA Medical Systems. The global cardiovascular medical lasers market is expected to grow from $0. Major players in the cardiovascular medical lasers market are Boston Scientific Corp, Cardiovascular Systems, AngioDynamics, Royal Philips NV, and RA Medical Systems. The global cardiovascular medical lasers market is expected to grow from $0.

Intrado Digital Media | September 27, 2021

Read More 'CSII' Stories Here

CSII Price Returns

1-mo -8.39%
3-mo -8.19%
6-mo -13.50%
1-year -13.12%
3-year -9.89%
5-year 38.57%
YTD -23.40%
2020 -9.94%
2019 70.55%
2018 20.26%
2017 -2.15%
2016 60.12%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 1.0492 seconds.